Literature DB >> 31755637

Deep Brain Stimulation for Multiple Sclerosis Tremor: A Meta-Analysis.

Nicholas J Brandmeir1,2, Ann Murray3,2, Cletus Cheyuo1,2, Christopher Ferari4, Ali R Rezai1,2.   

Abstract

OBJECTIVES: To examine the effect of deep brain stimulation (DBS) on multiple sclerosis (MS)-tremor, as measured by a normalized scale of tremor severity, with a meta-analysis of the published literature.
METHODS: Medline and EBSCO Host (January, 1998 to June, 2018) were systematically reviewed with librarian guidance, using the keywords "Deep brain stimulation" and "multiple sclerosis." Bibliographies and experts in the field were also consulted to identify missed articles. All therapeutic studies on DBS for MS-tremor, reported in the English language, within the study period were included. Papers that reported outcomes without a measure of central tendency and/or distribution were excluded. The papers were read in their entirety and graded for risk of bias according to the American Academy of Neurology (AAN) standards. To maximize statistical power, papers using different stimulation targets were grouped together. Outcomes were reported with the Fahn-Tolosa-Marin scale (FTM), the Bain-Finchley scale (CRS) and 3- and 4-point tremor severity scales and normalized with a Hedges g.
RESULTS: The search produced 13 studies suitable for meta-analysis. The random-effects meta-analysis showed that DBS improved the Hedges standardized mean tremor score by 2.86 (95%CI 2.03-3.70, p < .00001). Heterogeneity was high, with an I2 of 84%, suggesting that random effects model is more appropriate. Adverse event rates varied from 8% to 50%.
CONCLUSIONS: This meta-analysis provides level III evidence that DBS may improve MS-related tremor as measured by standardized tremor severity scales.
© 2019 International Neuromodulation Society.

Entities:  

Keywords:  DBS; MS; deep brain stimulation; multiple sclerosis; tremor

Mesh:

Year:  2019        PMID: 31755637      PMCID: PMC7457309          DOI: 10.1111/ner.13063

Source DB:  PubMed          Journal:  Neuromodulation        ISSN: 1094-7159


  29 in total

1.  Stimulation of the subthalamic nucleus in Parkinson's disease: a 5 year follow up.

Authors:  W M M Schüpbach; N Chastan; M L Welter; J L Houeto; V Mesnage; A M Bonnet; V Czernecki; D Maltête; A Hartmann; L Mallet; B Pidoux; D Dormont; S Navarro; P Cornu; A Mallet; Y Agid
Journal:  J Neurol Neurosurg Psychiatry       Date:  2005-12       Impact factor: 10.154

2.  Kinematic analysis of thalamic versus subthalamic neurostimulation in postural and intention tremor.

Authors:  Jan Herzog; Wolfgang Hamel; Roland Wenzelburger; Monika Pötter; Marcus O Pinsker; Jan Bartussek; Andre Morsnowski; Frank Steigerwald; Günther Deuschl; Jens Volkmann
Journal:  Brain       Date:  2007-04-17       Impact factor: 13.501

Review 3.  Deep brain stimulation of the subthalamic nucleus for the treatment of Parkinson's disease.

Authors:  Alim Louis Benabid; Stephan Chabardes; John Mitrofanis; Pierre Pollak
Journal:  Lancet Neurol       Date:  2009-01       Impact factor: 44.182

4.  Prevalence of tremor in multiple sclerosis and associated disability in the Olmsted County population.

Authors:  Sean J Pittock; Robyn L McClelland; William T Mayr; Moses Rodriguez; Joseph Y Matsumoto
Journal:  Mov Disord       Date:  2004-12       Impact factor: 10.338

5.  Suppression of intention tremor by contingent deep-brain stimulation.

Authors:  J Brice; L McLellan
Journal:  Lancet       Date:  1980-06-07       Impact factor: 79.321

6.  Bilateral deep brain stimulation of the pedunculopontine nucleus for Parkinson's disease.

Authors:  Puneet Plaha; Steven S Gill
Journal:  Neuroreport       Date:  2005-11-28       Impact factor: 1.837

7.  A prospective study of thalamic deep brain stimulation for the treatment of movement disorders in multiple sclerosis.

Authors:  J Hooper; R Taylor; B Pentland; I R Whittle
Journal:  Br J Neurosurg       Date:  2002-04       Impact factor: 1.596

8.  Deep brain stimulation for movement disorders. Considerations on 276 consecutive patients.

Authors:  Angelo Franzini; Roberto Cordella; Giuseppe Messina; Carlo Efisio Marras; Luigi Michele Romito; Francesco Carella; Alberto Albanese; Michele Rizzi; Nardo Nardocci; Giovanna Zorzi; Edvin Zekay; Giovanni Broggi
Journal:  J Neural Transm (Vienna)       Date:  2011-05-20       Impact factor: 3.575

9.  Safety and efficacy of dual-lead thalamic deep brain stimulation for patients with treatment-refractory multiple sclerosis tremor: a single-centre, randomised, single-blind, pilot trial.

Authors:  Seth F Oliveria; Ramon L Rodriguez; Dawn Bowers; Daniel Kantor; Justin D Hilliard; Erin H Monari; Bonnie M Scott; Michael S Okun; Kelly D Foote
Journal:  Lancet Neurol       Date:  2017-06-20       Impact factor: 44.182

10.  Symptomatic Management of Multiple Sclerosis-Associated Tremor Among Participants in the NARCOMS Registry.

Authors:  William Meador; Amber R Salter; John R Rinker
Journal:  Int J MS Care       Date:  2016 May-Jun
View more
  1 in total

1.  Connectomic analysis of unilateral dual-lead thalamic deep brain stimulation for treatment of multiple sclerosis tremor.

Authors:  Joshua K Wong; Bhavana Patel; Erik H Middlebrooks; Justin D Hilliard; Kelly D Foote; Michael S Okun; Leonardo Almeida
Journal:  Brain Commun       Date:  2022-03-15
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.